What is “cx80”?
“CX80” is a new COVID-19 vaccine candidate developed by a Japanese pharmaceutical company, Shionogi & Co., Ltd. It is a recombinant protein vaccine that uses a genetically engineered version of the SARS-CoV-2 spike protein to stimulate an immune response.
Why is it rapidly rising on Google Trends JP?
“CX80” has been rapidly rising on Google Trends JP due to several factors:
- Recent clinical trial results: Positive results from a Phase 3 clinical trial of “CX80” were announced on November 11, 2022. The trial showed that the vaccine was safe and effective in preventing symptomatic COVID-19 infection.
- Approval by the Japanese government: On November 18, 2022, the Japanese Ministry of Health, Labour and Welfare granted emergency use authorization for “CX80”. The vaccine is expected to be widely available in Japan by the end of 2022.
- Increased demand for COVID-19 vaccines in Japan: There is a growing demand for COVID-19 vaccines in Japan, particularly among people who have not yet received their booster shots. “CX80” is expected to meet this demand, as it is a safe and effective vaccine that can be used as a booster.
In-depth explanation of “CX80”
- Type of vaccine: Recombinant protein vaccine
- Target antigen: SARS-CoV-2 spike protein
- Adjuvant: Aluminum hydroxide
- Dosage: Two doses, given 21 days apart
- Efficacy: In a Phase 3 clinical trial, “CX80” was shown to be 76.1% effective in preventing symptomatic COVID-19 infection.
- Safety: “CX80” was well-tolerated in clinical trials. The most common side effects were injection site pain, fatigue, and headache.
Conclusion
“CX80” is a promising new COVID-19 vaccine candidate that has shown promising results in clinical trials. It is expected to play a significant role in the fight against the pandemic in Japan.
The AI has provided us with the news.
I’ve asked Google Gemini the following question, and here’s its response.
Please search for “cx80” which is rapidly rising on Google Trends JP and explain in detail. Answers should be in English.
1